Expression of BCR-ABL, E2A-PBX1, and MLL-AF4 Fusion Transcripts in Newly Diagnosed Children with Acute Lymphoblastic Leukemia: A Children's Cancer Group Initiative

References

• Cortes J. E., Kantarjian H. M. Acute lymphoblastic leukemia. Cancer 1995; 76: 2393–2417
   PubMed Web of Science ®Google Scholar
• Pui C. H, Crist W. M., Look A. T. Biology and clinical significance of cytogenetic abnormalities in childhood acute lymphoblastic leukemia. Blood 1990; 76: 1449–1463
   PubMed Web of Science ®Google Scholar
• Raimondi S. C., Privitera E., Williams D. L., Look A. T., Behm F., Rivera G. K., Crist W. M., Pui C.-H. New recurring chromosomal translocations in childhood acute lymphoblastic leukemia. Blood 1991; 77: 2016–2022
   PubMed Web of Science ®Google Scholar
• Trueworthy R., Shuster J., Look T., Crist W., Borowitz M., Carroll A., Frankel L., Harris M., Wagner H., Haggard M., Mosijczuk A., Pullen J., Steuber P., Land V. Ploidy of lymphoblasts is the strongest predictor of treatment outcome in B-progenitor cell acute lymphoblastic leukemia of childhood: A Pediatric Oncology Group study. J Clin Oncol 1992; 10: 606–613
   PubMed Web of Science ®Google Scholar
• Pui C. H, Carroll A. J., Raimondi S. C., Land V. J., Crist W. M., Shuster J. J., Williams D. L., Pullen D. J., Borowitz M. J., Behm F. G., Look A. T. Clinical presentation, karyotypic characterization, and treatment outcome of childhood acute lymphoblastic leukemia with a near-haploid or hypodiploid < 45 line. Blood 1990; 75: 1170–1177
   PubMed Web of Science ®Google Scholar
• Crist W. M., Carroll A. J., Shuster J. J., Behm F. G., Whitehead M., Vietti T. J., Look A. T., Mahoney D., Ragab A., Pullen D. J., Land V. J. Poor prognosis of children with pre-B acute lymphoblastic leukemia is associated with the t(1;19) (q23;p13): a Pediatric Oncology Group Study. Blood 1990; 76: 117–122
   PubMed Web of Science ®Google Scholar
• Raimondi S. C., Behm F. G., Roberson P. K., Williams D. L., Pui C. H, Crist W. M., Look A. T., Rivera G. K. Cytogenetics of pre-B acute lymphoblastic leukemia with emphasis on prognostic implications of the t(1;19). J Clin Oncol 1990; 8: 1380–1388
   PubMed Web of Science ®Google Scholar
• Pui C. H, Raimondi S. C., Hancock M. L., Rivera G. K., Ribeiro R. V., Mahmoud H. H., Sandlund J. T., Crist W. M., Behm F. G. Immunologic, cytogenetic, and clinical characterization of childhood acute lymphoblastic leukemia with the t(1;19)(q23;p13) or its derivative. J Clin Oncol 1994; 12: 2601–2606
   PubMed Web of Science ®Google Scholar
• Privitera E., Luciano A., Ronchetti D., Aricoá M., Santostasi T., Basso G., Biondi A. Molecular variants of the 1;19 chromosomal translocation in pediatric acute lymphoblastic leukemia (ALL). Leukemia 1994; 8: 554–559
   PubMed Web of Science ®Google Scholar
• Hunger S. P. Chromosomal translocations involving the E2A gene in acute lymphoblastic leukemia: clinical features and molecular pathogenesis. Blood 1996; 87: 1211–1224
   PubMed Web of Science ®Google Scholar
• Pui C. H, Frankel L. S., Carroll A. J., Raimondi S. C., Shuster J. J., Head D. R., Crist W. M., Land V. J., Pullen D. J., Steuber C. P., Behm F. G., Borowitz M. J. Clinical characteristics and treatment outcome of childhood acute lymphoblastic leukemia with the t(4;11)(q21;q23): A collaborative study of 40 cases. Blood 1991; 77: 440–447
   PubMed Web of Science ®Google Scholar
• Pui C. H., Carroll A. J., Raimondi S. C., Shusterr J. J., Crist W. M., Pullen J. D. Childhood acute lymphoblastic leukemia with the t(4;11) (q21;q23): an update. Blood 1993; 83: 2384–2385
   Web of Science ®Google Scholar
• Heerema N. A., Arthur D. C., Sather H., Albo V., Feusner J., Lange B. J., Steinherz P. G., Zeltzer P., Hammond D., Reaman G. H. Cytogenetic features of infants less than 12 months of age at diagnosis of acute lymphoblastic leukemia: impact of the 11q23 breakpoint on outcome: a report of the Childrens Cancer Group. Blood 1994; 83: 2274–2284
   PubMed Web of Science ®Google Scholar
• Morrissey J., Tkachuk D. C., Milatovich A., Francke U., Link M., Cleary M. L. A serine/proline-rich protein is fused to HRX in t(4;11) acute leukemia. Blood 1993; 81: 1124–1131
   PubMed Web of Science ®Google Scholar
• Crist W., Carroll A., Shuster J., Jackson J., Head D., Borowitz M., Behm F., Link M., Steuber P., Ragab A., Hirt A., Brock B., Land V., Pullen J. Philadelphia chromosome positive childhood acute lymphoblastic leukemia: clinical and cytogenetic characteristics and treatment outcome. A Pediatric Oncology Group study. Blood 1990; 76: 489–494
   PubMed Web of Science ®Google Scholar
• Fletcher J. A., Lynch E. A., Kimball V. M., Donnelly M., Tantravahi R., Sallan S. E. Translocation (9;22) is associated with extremely poor prognosis in intensively treated children with acute lymphoblastic leukemia. Blood 1991; 77: 435–439
   PubMed Web of Science ®Google Scholar
• Russo C., Carroll A., Kohler S., Borowitz M., Amylon M., Homans A., Kedar A., Shuster J., Land V., Crist W., Pullen J., Link M. Philadelphia chromosome and monosomy 7 in childhood acute lymphoblastic leukemia: A Pediatric Oncology Group study. Blood 1991; 77: 1050–1056
   PubMed Web of Science ®Google Scholar
• Campana D., Pui C.-H. Detection of minimal residual disease in acute leukemia: Methodologic advances and clinical significance. Blood 1995; 85: 1416–1434
   PubMed Web of Science ®Google Scholar
• Maurer J., Janssen J. W. G., Thiel E., van Denderen J., Ludwig W. D, Aydemir U U., Heinze B., Fonatsch C., Harbott J., Reiter A., Riehm H., Hoelzer D., Bartram C. R. Detection of chimeric BCR-ABL genes in acute lymphoblastic leukaemia by the polymerase chain reaction. Lancet 1991; 337: 1055–1058
   PubMed Web of Science ®Google Scholar
• Izraeli S., Janssen J. W. G., Haas O. A., Harbott J., Brok-Simoni F., Walther J. U., Kovar H., Henn T., Ludwig W. D, Reiter A., Rechavi G., Bartram C. R., Gadner H., Lion T. Detection and clinical relevance of genetic abnormalities in pediatric acute lymphoblastic leukemia: A comparison between cytogenetic and polymerase chain reaction analyses. Leukemia 1993; 7: 671–678
   PubMed Web of Science ®Google Scholar
• Romana S. P., Poirel H., Leconiat M., Flexor M. A., Mauchauffé M., Jonveaux P., Macintyre E. A., Berger R., Bernard O. A. High frequency of t(12;21) in child-hood B-lineage acute lymphoblastic leukemia. Blood 1995; 86: 4263–4269
   PubMed Web of Science ®Google Scholar
• Shurtleff S. A., Buijs A., Behm F. G., Rubnitz J. E., Raimondi S. C., Hancock M. L., Chan G. C. F., Pui C. H., Grosveld G., Downing J. R. TEL/AML1 fusion resulting from a cryptic t(12;21) is the most common genetic lesion in pediatric ALL and defines a subgroup of patients with an excellent prognosis. Leukemia 1995; 9: 1985–1989
   PubMed Web of Science ®Google Scholar
• Uckun F. M., Downing J. R., Gunther R., Chelstrom L. M., Finnegan D., Land V. J., Borowitz M. J., Carroll A. J., Crist W. M. Human t(1;19) (q23;p13) pre-B acute lymphoblastic leukemia in mice with severe combined immunodeficiency. Blood 1993; 81: 3052–3062
   PubMed Web of Science ®Google Scholar
• Uckun F. M., Downing J. R., Chelstrom L. M., Gunther R., Ryan M., Simon J., Carroll A. J., Tuel-Ahlgren L., Crist W. M. Human t(4;111) (q21;q23) acute lymphoblastic leukemia in mice with severe combined immunodeficiency. Blood 1994; 83: 859–865
   Google Scholar
• Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 1966; 50: 163–170
   PubMedGoogle Scholar
• Peto R., Pike M. C., Armitage P., et al. Design and analysis of randomized clinical trials requiring prolonged observation of each patient, II. Analysis and examples. Br J Cancer 1977; 35: 1–39
   PubMed Web of Science ®Google Scholar
• Breslow N. Analysis of survival data under the proportional hazards model. lnt Stat Rev 1975; 43: 45–58
   Web of Science ®Google Scholar
• Mastrangelo R., Poplack D., Bleyer A., Riccardi R., Sather H., D'Angio G. Report and recommendations of the Rome Workshop concerning poor-prognosis acute lymphoblastic leukemia in children: Biologic bases for staging, stratification, and treatment. Med Pediatr Oncol 1986; 14: 191–194
   PubMedGoogle Scholar
• Smith M., Arthur D., Camitta B., Carroll A. J., Crist W., Gaynon P., Gelber R., Heerema N., Korn E. L., Link M., Murphy S., Pui C. H., Pullen J., Reaman G., Sallan S. E., Sather H., Shuster J., Simon R., Trigg M., Tubergen D., Uckun F., Ungeleider R. Uniform approach to the risk classification and treatment assignment for children with acute lymphoblastic leukemia. J Clin Oncol 1996; 14: 18–24
   PubMed Web of Science ®Google Scholar